These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Molecular insights into the premature aging disease progeria. Vidak S; Foisner R Histochem Cell Biol; 2016 Apr; 145(4):401-17. PubMed ID: 26847180 [TBL] [Abstract][Full Text] [Related]
28. Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson-Gilford progeria syndrome fibroblasts. Bikkul MU; Clements CS; Godwin LS; Goldberg MW; Kill IR; Bridger JM Biogerontology; 2018 Dec; 19(6):579-602. PubMed ID: 29907918 [TBL] [Abstract][Full Text] [Related]
29. Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerin. Yang SH; Chang SY; Ren S; Wang Y; Andres DA; Spielmann HP; Fong LG; Young SG Hum Mol Genet; 2011 Feb; 20(3):436-44. PubMed ID: 21088111 [TBL] [Abstract][Full Text] [Related]
30. Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin. Wang Y; Panteleyev AA; Owens DM; Djabali K; Stewart CL; Worman HJ Hum Mol Genet; 2008 Aug; 17(15):2357-69. PubMed ID: 18442998 [TBL] [Abstract][Full Text] [Related]
32. Vascular smooth muscle cell loss underpins the accelerated atherosclerosis in Hutchinson-Gilford progeria syndrome. Hamczyk MR; Andrés V Nucleus; 2019 Dec; 10(1):28-34. PubMed ID: 30900948 [TBL] [Abstract][Full Text] [Related]
33. Blocking protein farnesylation improves nuclear shape abnormalities in keratinocytes of mice expressing the prelamin A variant in Hutchinson-Gilford progeria syndrome. Wang Y; Ostlund C; Worman HJ Nucleus; 2010; 1(5):432-9. PubMed ID: 21326826 [TBL] [Abstract][Full Text] [Related]
34. Progeria, the nucleolus and farnesyltransferase inhibitors. Mehta IS; Bridger JM; Kill IR Biochem Soc Trans; 2010 Feb; 38(Pt 1):287-91. PubMed ID: 20074076 [TBL] [Abstract][Full Text] [Related]
35. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Scaffidi P; Misteli T Nat Med; 2005 Apr; 11(4):440-5. PubMed ID: 15750600 [TBL] [Abstract][Full Text] [Related]
36. Progerin-Induced Replication Stress Facilitates Premature Senescence in Hutchinson-Gilford Progeria Syndrome. Wheaton K; Campuzano D; Ma W; Sheinis M; Ho B; Brown GW; Benchimol S Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28483909 [TBL] [Abstract][Full Text] [Related]
37. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Eriksson M; Brown WT; Gordon LB; Glynn MW; Singer J; Scott L; Erdos MR; Robbins CM; Moses TY; Berglund P; Dutra A; Pak E; Durkin S; Csoka AB; Boehnke M; Glover TW; Collins FS Nature; 2003 May; 423(6937):293-8. PubMed ID: 12714972 [TBL] [Abstract][Full Text] [Related]
39. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. Mallampalli MP; Huyer G; Bendale P; Gelb MH; Michaelis S Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14416-21. PubMed ID: 16186497 [TBL] [Abstract][Full Text] [Related]
40. Dysregulated interactions between lamin A and SUN1 induce abnormalities in the nuclear envelope and endoplasmic reticulum in progeric laminopathies. Chen ZJ; Wang WP; Chen YC; Wang JY; Lin WH; Tai LA; Liou GG; Yang CS; Chi YH J Cell Sci; 2014 Apr; 127(Pt 8):1792-804. PubMed ID: 24522183 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]